U.s. defense logistics agency exercises 1-year option period in applied dna counterfeit mitigation contract

Stony brook, ny / accesswire / july 18, 2024 / applied dna sciences, inc. (nasdaq:apdn) (applied dna), a leader in pcr-based dna technologies, today announced that the u.s. defense logistics agency (dla) exercised the first one-year option period of a three-year base contract with two one-year option periods entered into in may 2021. the contract supports dla's counterfeit mitigation initiatives and product verification and testing programs specific to fsc 5962 microcircuits.
DNA Ratings Summary
DNA Quant Ranking